Real-world Experience of Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B Cell Lymphoma

Wood, Erica (Primary Chief Investigator (PCI))
Hawkes, Eliza (Chief Investigator (CI))
McQuilten, Zoe (Chief Investigator (CI))

Acute & Critical Care

Project: Research

Project Description

Collection and Analysis of LaRDR data on Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B Cell Lymphoma

Short title	Polatuzumab RWD study
Status	Finished
Effective start/end date	13/12/21 → 30/04/23

Keywords

Lymphoma